[Federal Register Volume 68, Number 231 (Tuesday, December 2, 2003)]
[Notices]
[Page 67476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29975]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 19, 2003, and published in the Federal 
Register on September 2, 2003, (68 FR 52225), LinZhi International, 
Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made 
application to the Drug Enforcement Administration for registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphetamine (7405)...  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Secobarbital (2315)........................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of controlled 
substances to make drug testing reagents and controls.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of LinZhi International, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Lin-Zhi 
International, Inc. to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as bulk 
manufacturer of the basic classes of controlled substances listed is 
granted.

    Dated: November 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-29975 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M